Home Influenza [Therapeutics] Therapeutics
Influenza roadmap:
Control Strategies

Roadmap for the development of disease control strategies for influenza

Download Influenza-control-development-roadmap

B

Therapeutics

Therapeutics

Research Question

  • To develop effective and affordable therapeutics for influenza viruses for targeted species
  • Develop strategies for therapeutics use

Research Gaps and Challenges

  • Risk of the emergence and spread of resistance
  • Identify appropriate uses of antivirals in animal
  • Residuals in products and environment (withdrawal time and MRL)
  • Cost of therapeutics for animal production systems
  • Preservation of therapeutics for human use and possible high value companion animals to reduce antiviral resistance development
  • Need to have clear definitions on how to determine when a flock/bird is negative
  • Is there a need/market for therapeutics in controlling outbreaks?

Solution Routes

  • Development of flu antivirals (particularly for horses and companion animals?)—reduce virus shedding while avoiding spread of drug resistance esp. to human/swine flu
  • Demonstrate safety for animal, human and environment of new therapeutics, defining
  • Withdrawal period and MRL
  • Explore approaches that might overcome resistance issues like siRNA
  • Define how to use therapeutics in control: use and depopulate approach or use in animals that don’t enter the food chain: Zoo birds,
    endangered species, hi value breeders, etc.
  • Decision tool or decision matrix to guide practitioners should be made
    available
  • Establish if therapeutics have been implemented/used regionally

Dependencies

  • Involve public health side here

State Of the Art

  • Currently therapeutics can’t be used in production animals as stamping out is applied for biosafety reasons